))
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
1
Disrupting Stagnant Women’s Reproductive Health Ecosystem with Safer More Accessible Options with Kathy Lee-Sepsick Femasys TRANSCRIPT
Kathy Lee-Sepsick, President, Founder, and CEO of Femasys, uses innovative medical technologies to address unmet women's reproductive healthcare needs. Femasyis is developing treatments for infertility and birth control and diagnostic tools to support its treatment offerings. The devices are intentionally designed to be more accessible, less invasi…
…
continue reading
1
Disrupting Stagnant Women’s Reproductive Health Ecosystem with Safer More Accessible Options with Kathy Lee-Sepsick Femasys
21:28
21:28
Play later
Play later
Lists
Like
Liked
21:28
Kathy Lee-Sepsick, President, Founder, and CEO of Femasys, uses innovative medical technologies to address unmet women's reproductive healthcare needs. Femasyis is developing treatments for infertility and birth control and diagnostic tools to support its treatment offerings. The devices are intentionally designed to be more accessible, less invasi…
…
continue reading
1
Population Health Insights on Closing Healthcare Gaps to Improve Health Equity with Kim Brunisholz Johnson & Johnson TRANSCRIPT
Kim Brunisholz, director of Population Health Research at Johnson & Johnson, is conducting research to bridge the gap between evidence-based care and its implementation in routine clinical practice. Overcoming the challenges of translating research into practice requires understanding patient-provider perspectives and using qualitative and quantita…
…
continue reading
1
Population Health Insights on Closing Healthcare Gaps to Improve Health Equity with Kim Brunisholz Johnson & Johnson
19:09
19:09
Play later
Play later
Lists
Like
Liked
19:09
Kim Brunisholz, director of Population Health Research at Johnson & Johnson, is conducting research to bridge the gap between evidence-based care and its implementation in routine clinical practice. Overcoming the challenges of translating research into practice requires understanding patient-provider perspectives and using qualitative and quantita…
…
continue reading
Nick Orser, General Manager at Verato, highlights the importance of trusted identity data in the healthcare industry and how master data management can help healthcare organizations deliver personalized patient experiences. The proliferation of data sources and health record systems makes maintaining a single, accurate view of each patient challeng…
…
continue reading
1
Master Data Management Enabling Trusted Identity in Healthcare with Nick Orser Verato
23:03
23:03
Play later
Play later
Lists
Like
Liked
23:03
Nick Orser, General Manager at Verato, highlights the importance of trusted identity data in the healthcare industry and how master data management can help healthcare organizations deliver personalized patient experiences. The proliferation of data sources and health record systems makes maintaining a single, accurate view of each patient challeng…
…
continue reading
Richard Mackey is the Chief Technology Officer at CCS, a company that provides chronic care management services focusing on diabetes. CCS uses machine learning and generative AI to analyze patient data from continuous glucose monitors and patient interactions to predict potential issues and proactively provide personalized information and support. …
…
continue reading
1
Leveraging Generative AI to Manage Chronic Care Challenges with Richard Mackey CCS
18:58
18:58
Play later
Play later
Lists
Like
Liked
18:58
Richard Mackey is the Chief Technology Officer at CCS, a company that provides chronic care management services focusing on diabetes. CCS uses machine learning and generative AI to analyze patient data from continuous glucose monitors and patient interactions to predict potential issues and proactively provide personalized information and support. …
…
continue reading
1
Transdermal Patch Treats Basal Cell Carcinoma Noninvasive Alternative to Mohs Surgery with Dr. Raza Bokhari Medicus Pharma TRANSCRIPT
Dr. Raza Bokhari, Executive Chairman and CEO of Medicus Pharma, has developed a novel, non-invasive treatment for basal cell carcinoma, the most common form of skin cancer. This cost-effective transdermal Skinject patch delivers a chemotherapeutic agent applied in a clinician's office over three sessions to remove the lesion, potentially avoiding t…
…
continue reading
1
Transdermal Patch Treats Basal Cell Carcinoma Noninvasive Alternative to Mohs Surgery with Dr. Raza Bokhari Medicus Pharma
24:49
24:49
Play later
Play later
Lists
Like
Liked
24:49
Dr. Raza Bokhari, Executive Chairman and CEO of Medicus Pharma, has developed a novel, non-invasive treatment for basal cell carcinoma, the most common form of skin cancer. This cost-effective transdermal Skinject patch delivers a chemotherapeutic agent applied in a clinician's office over three sessions to remove the lesion, potentially avoiding t…
…
continue reading
Scott Xiao, Co-Founder and CEO of Luminopia is developing a virtual reality-based treatment for amblyopia, also known as Lazy Eye in children. A traditional treatment is eye patching, which children find difficult to comply with. The Luminopia approach allows children to use a VR headset to watch content licensed from Sesame Street and Nickelodeon …
…
continue reading
1
VR-Based Treatment for Children with Amblyopia with Scott Xiao Luminopia
17:55
17:55
Play later
Play later
Lists
Like
Liked
17:55
Scott Xiao, Co-Founder and CEO of Luminopia is developing a virtual reality-based treatment for amblyopia, also known as Lazy Eye in children. A traditional treatment is eye patching, which children find difficult to comply with. The Luminopia approach allows children to use a VR headset to watch content licensed from Sesame Street and Nickelodeon …
…
continue reading
1
Novel Silver Nanoparticle Antimicrobial Technology Combats Healthcare-Associated Infections with Shaun Rothwell EVOQ Nano TRANSCRIPT
Shaun Rothwell is Chairman and CEO of EVOQ Nano, a company focused on developing antimicrobial technology to combat healthcare-associated infections. EVOQ nanotechnology involves a unique non-ionic silver nanoparticle that can effectively kill even the most dangerous drug-resistant bacteria. These nanoparticles can be incorporated into medical devi…
…
continue reading
1
Novel Silver Nanoparticle Antimicrobial Technology Combats Healthcare-Associated Infections with Shaun Rothwell EVOQ Nano
18:51
18:51
Play later
Play later
Lists
Like
Liked
18:51
Shaun Rothwell is Chairman and CEO of EVOQ Nano, a company focused on developing antimicrobial technology to combat healthcare-associated infections. EVOQ nanotechnology involves a unique non-ionic silver nanoparticle that can effectively kill even the most dangerous drug-resistant bacteria. These nanoparticles can be incorporated into medical devi…
…
continue reading
1
Exposome Platform Unlocks New Possibilities for Diagnosis and Treatment of Autism and Other Brain Disorders with Manish Arora LinusBio TRANSCRIPT
Manish Arora, the CEO and Co-Founder of LinusBio, is developing technologies to measure and analyze the exposome which reveals lifelong exposure to environmental factors. Their platform measures molecular signatures in hair samples for early detection and diagnosis of conditions such as autism, where traditional observational methods can be limited…
…
continue reading
1
Exposome Platform Unlocks New Possibilities for Diagnosis and Treatment of Autism and Other Brain Disorders with Manish Arora LinusBio
24:02
24:02
Play later
Play later
Lists
Like
Liked
24:02
Manish Arora, the CEO and Co-Founder of LinusBio, is developing technologies to measure and analyze the exposome which reveals lifelong exposure to environmental factors. Their platform measures molecular signatures in hair samples for early detection and diagnosis of conditions such as autism, where traditional observational methods can be limited…
…
continue reading
1
Health AI Assistant Reduces No-Show Rates Increases Patient Engagement with Shailu Verma Mila Health TRANSCRIPT
Shailu Verma, CEO and Co-Founder of Mila Health is addressing missed appointments and no-shows for appointments to improve patient outcomes, drive staff efficiency, and reduce clinician stress. The Mila platform aims to automate time-consuming tasks, allowing staff to manage their schedules and patient flow better. This AI-powered assistant drives …
…
continue reading
1
Health AI Assistant Reduces No-Show Rates Increases Patient Engagement with Shailu Verma Mila Health
22:54
22:54
Play later
Play later
Lists
Like
Liked
22:54
Shailu Verma, CEO and Co-Founder of Mila Health is addressing missed appointments and no-shows for appointments to improve patient outcomes, drive staff efficiency, and reduce clinician stress. The Mila platform aims to automate time-consuming tasks, allowing staff to manage their schedules and patient flow better. This AI-powered assistant drives …
…
continue reading
1
Innovative Surgical Techniques Transform Lymphedema Treatment with Dr. Joseph Dayan Institute for Advanced Reconstruction TRANSCRIPT
Dr. Joseph Dayan is a board-certified plastic and reconstructive surgeon at the Institute for Lymphatic Surgery and Innovation, a division of the Institute for Advanced Reconstruction. Doctors have traditionally focused on treating cancer rather than long-term effects such as lymphedema, a swelling condition caused by dysfunction of the lymphatic s…
…
continue reading
1
Innovative Surgical Techniques Transform Lymphedema Treatment with Dr. Joseph Dayan Institute for Advanced Reconstruction
21:02
21:02
Play later
Play later
Lists
Like
Liked
21:02
Dr. Joseph Dayan is a board-certified plastic and reconstructive surgeon at the Institute for Lymphatic Surgery and Innovation, a division of the Institute for Advanced Reconstruction. Doctors have traditionally focused on treating cancer rather than long-term effects such as lymphedema, a swelling condition caused by dysfunction of the lymphatic s…
…
continue reading
Dr. Tom Coughlin, Founder and CEO of OncRef, has developed a platform that provides oncologists with a single source of information to keep up with the rapidly evolving field of cancer research and therapies. OncRef is addressing oncologists' information overload and time constraints, as well as curating and structuring the vast amount of available…
…
continue reading
1
Managing the Flood of Cancer Data to Support Oncologists with Dr. Tom Coughlin OncRef
19:37
19:37
Play later
Play later
Lists
Like
Liked
19:37
Dr. Tom Coughlin, Founder and CEO of OncRef, has developed a platform that provides oncologists with a single source of information to keep up with the rapidly evolving field of cancer research and therapies. OncRef is addressing oncologists' information overload and time constraints, as well as curating and structuring the vast amount of available…
…
continue reading
1
Lab Data Insights Unlock Predictive Power to Improve Patient Care and Healthcare Efficiency with Bradley Bostic hc1 TRANSCRIPT
Bradley Bostic, CEO of hc1, uses advanced data science, AI, and natural language processing to identify optimal patient testing, better predict disease development, and provide insights that can help prevent disease progression. The use of lab data is crucial for making diagnostic decisions, yet the potential of leveraging data is not being realize…
…
continue reading
1
Lab Data Insights Unlock Predictive Power to Improve Patient Care and Healthcare Efficiency with Bradley Bostic hc1
23:38
23:38
Play later
Play later
Lists
Like
Liked
23:38
Bradley Bostic, CEO of hc1, uses advanced data science, AI, and natural language processing to identify optimal patient testing, better predict disease development, and provide insights that can help prevent disease progression. The use of lab data is crucial for making diagnostic decisions, yet the potential of leveraging data is not being realize…
…
continue reading
Niels Riedemann, the CEO, Founder, and Executive Director of the Board of InflaRx, explains that InflaRx develops pioneering anti-inflammatory therapeutics against a specific portion of the complement cascade, a part of the body’s immune system that responds to infectious microbes. By applying its proprietary monoclonal anti-C5a and anti-C5aR techn…
…
continue reading
